Evidence map›Paper›PMID 27723720›Full record

ArticleNature cell biology2016

ETAA1 acts at stalled replication forks to maintain genome integrity.

Thomas E Bass, Jessica W Luzwick, Gina Kavanaugh, Clinton Carroll, Huzefa Dungrawala, Gloria G Glick, Michael D Feldkamp, Reid Putney, Walter J Chazin, David Cortez

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 249 citations in OpenAlex.

  1. Article
  2. Review
  3. Capturing ATR-ATRIP in the act of activation.Nature structural & molecular biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. RPA-independent activation of the ATR/CHK1 pathway.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Thomas E BassDepartment of Biochemistry, Vanderbilt University School of Medicine, 613 Light Hall, 2215 Garland Avenue, Nashville, Tennessee 37232, USA.
Jessica W LuzwickDepartment of Biochemistry, Vanderbilt University School of Medicine, 613 Light Hall, 2215 Garland Avenue, Nashville, Tennessee 37232, USA.
Gina KavanaughDepartment of Biochemistry, Vanderbilt University School of Medicine, 613 Light Hall, 2215 Garland Avenue, Nashville, Tennessee 37232, USA.
Clinton CarrollDepartment of Biochemistry, Vanderbilt University School of Medicine, 613 Light Hall, 2215 Garland Avenue, Nashville, Tennessee 37232, USA.
Huzefa DungrawalaDepartment of Biochemistry, Vanderbilt University School of Medicine, 613 Light Hall, 2215 Garland Avenue, Nashville, Tennessee 37232, USA.
Gloria G GlickDepartment of Biochemistry, Vanderbilt University School of Medicine, 613 Light Hall, 2215 Garland Avenue, Nashville, Tennessee 37232, USA.
Michael D FeldkampCenter for Structural Biology, Vanderbilt University, Nashville, Tennessee 37232, USA.
Reid PutneyCenter for Structural Biology, Vanderbilt University, Nashville, Tennessee 37232, USA.
Walter J ChazinCenter for Structural Biology, Vanderbilt University, Nashville, Tennessee 37232, USA.
David CortezDepartment of Biochemistry, Vanderbilt University School of Medicine, 613 Light Hall, 2215 Garland Avenue, Nashville, Tennessee 37232, USA.
Vanderbilt University · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
BIOCHEMICAL &CHEMICAL TRAINING FOR CANCER RESEARCHT32CA009582 · NCI · VANDERBILT UNIVERSITY · PI David K Cortez · 1987 to 2026
$8.8M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Analysis of the Replication Stress ResponseR01GM116616 · NIGMS · VANDERBILT UNIVERSITY · PI David K Cortez · 2015 to 2026
$5.4M
Function of the ATR-ATRIP ComplexR01CA102729 · NCI · VANDERBILT UNIVERSITY · PI CORTEZ, DAVID K · 2003 to 2018
$4.2M
Structural Basis for RPA Functions in DNA ProcessingR01GM065484 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 2003 to 2015
$3.9M
NCI NIH HHS K12 CA090625NCI NIH HHS P01 CA092584NCI NIH HHS R01 CA102729NCI NIH HHS T32 CA009582NIGMS NIH HHS R01 GM065484NIGMS NIH HHS R01 GM116616NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

The ATR checkpoint kinase coordinates cellular responses to DNA replication stress. Budding yeast contain three activators of Mec1 (the ATR orthologue); however, only TOPBP1 is known to activate ATR in vertebrates. We identified ETAA1 as a replication stress response protein in two proteomic screens. ETAA1-deficient cells accumulate double-strand breaks, sister chromatid exchanges, and other hallmarks of genome instability. They are also hypersensitive to replication stress and have increased frequencies of replication fork collapse. ETAA1 contains two RPA-interaction motifs that localize ETAA1 to stalled replication forks. It also interacts with several DNA damage response proteins including the BLM/TOP3α/RMI1/RMI2 and ATR/ATRIP complexes. It binds ATR/ATRIP directly using a motif with sequence similarity to the TOPBP1 ATR-activation domain; and like TOPBP1, ETAA1 acts as a direct ATR activator. ETAA1 functions in parallel to the TOPBP1/RAD9/HUS1/RAD1 pathway to regulate ATR and maintain genome stability. Thus, vertebrate cells contain at least two ATR-activating proteins.

Indexed as

Adaptor Proteins, Signal TransducingAntigens, SurfaceAtaxia Telangiectasia Mutated ProteinsCarrier ProteinsCell Cycle ProteinsCell LineDNA-Binding ProteinsDNA DamageDNA ReplicationGenome, HumanGenomic InstabilityHumansProtein Serine-Threonine KinasesProteomicsSignal TransductionAdaptor Proteins, Signal TransducingAntigens, SurfaceAtaxia Telangiectasia Mutated ProteinsATRIP protein, humanATR protein, humanCarrier ProteinsCell Cycle ProteinsDNA-Binding ProteinsETAA1 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID27723720
PMCPMC5245861
OpenAlexW2530188477

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.